A Study to Evaluate the Long Term Safety of OTX-TP (Sustained Release Travoprost) Intracanalicular Insert
Study sponsor: Ocular Therapeutix, Inc. · OCUL
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2020-02-10Actual
Enrollment · participants40Actual
Source updated2023-06-09Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.